Status:
NOT_YET_RECRUITING
Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Induction of Labor
Augmentation of Labor
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to compare between higher and lower dose of oxytocin to induce delivery in obese women. Researches will compare between low and high doses of oxytocin. the study gro...
Detailed Description
the duration and the progression of the first stage of labor is slower in obese women and oxytocin seems to be less effective in the treatment of protracted labor in obese women. There is no consensus...
Eligibility Criteria
Inclusion
- Women at term (37-42 weeks), requiring the use of oxytocin for induction of labor or for augmentation of labor.
- BMI 30 and above
- Viable singleton pregnancies
- Cephalic presentation.
- No contraindication for vaginal delivery
Exclusion
- Women with previous cesarean delivery
- Multiple pregnancy
- Multiple fetal malformations
- IUFD
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06990217
Start Date
June 1 2025
End Date
December 1 2027
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haemek Medical Center
Afula, Israel